pI: 4.1626 |
Length (AA): 209 |
MW (Da): 23034 |
Paralog Number:
1
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 7 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
8 | 95 | 1rl1 (A) | 139 | 226 | 23.00 | 0 | 1 | 0.78 | -0.99 |
12 | 131 | 2cg9 (X) | 18 | 134 | 30.00 | 0 | 1 | 0.78 | 0.43 |
4 | 86 | 4rzk (A) | 80 | 163 | 13.00 | 0.004 | 0.37 | 0.667429 | -1.25 |
8 | 125 | 1ejf (A) | 3 | 110 | 28.00 | 0.000000012 | 1 | 0.955893 | -1.13 |
12 | 128 | 2cg9 (X) | 18 | 131 | 31.00 | 0 | 0.99 | 0.891109 | -0.5 |
35 | 118 | 4rmb (A) | 501 | 582 | 39.00 | 0.47 | 0.31 | 0.462714 | 1.03 |
124 | 200 | 2az3 (A) | 55 | 127 | 37.00 | 0.1 | 0.42 | 0.646221 | 0.17 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | amastigotes. | Fernandes MC |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | metacyclic. | Fernandes MC |
Fernandes MC | Dual Transcriptome Profiling of Leishmania-Infected Human Macrophages Reveals Distinct Reprogramming Signatures. |
Ortholog group members (OG5_127481)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT3G03773 | p23 co-chaperone protein |
Arabidopsis thaliana | AT4G02450 | HSP20-like chaperone |
Babesia bovis | BBOV_III004670 | conserved hypothetical protein |
Brugia malayi | Bm1_30235 | Hypothetical 19.4 kDa protein ZC395.10 in chromosome III |
Candida albicans | CaO19.13172 | HSP90 associated co-chaperone |
Candida albicans | CaO19.5749 | HSP90 associated co-chaperone |
Caenorhabditis elegans | CELE_ZC395.10 | Protein ZC395.10 |
Cryptosporidium hominis | Chro.60200 | p23 co-chaperone |
Cryptosporidium parvum | cgd6_1630 | p23; HSP20-like chaperones fold |
Dictyostelium discoideum | DDB_G0268042 | hypothetical protein |
Drosophila melanogaster | Dmel_CG16817 | CG16817 gene product from transcript CG16817-RA |
Echinococcus granulosus | EgrG_001059400 | hsp90 co chaperone tebp |
Echinococcus multilocularis | EmuJ_001059400 | hsp90 co chaperone (tebp) |
Giardia lamblia | GL50803_10429 | Wos2 protein |
Homo sapiens | ENSG00000110958 | prostaglandin E synthase 3 (cytosolic) |
Leishmania braziliensis | LbrM.34.4450 | hypothetical protein, conserved |
Leishmania braziliensis | LbrM.20.0220 | hypothetical protein, conserved |
Leishmania donovani | LdBPK_354540.1 | Co-chaperone protein P23 |
Leishmania donovani | LdBPK_340230.1 | CS domain containing protein, putative |
Leishmania infantum | LinJ.35.4540 | hypothetical protein, conserved |
Leishmania infantum | LinJ.34.0230 | hypothetical protein, conserved |
Leishmania major | LmjF.34.0210 | hypothetical protein, conserved |
Leishmania major | LmjF.35.4470 | hypothetical protein, conserved |
Leishmania mexicana | LmxM.33.0210 | hypothetical protein, conserved |
Leishmania mexicana | LmxM.34.4470 | hypothetical protein, conserved |
Loa Loa (eye worm) | LOAG_07411 | hypothetical protein |
Mus musculus | ENSMUSG00000071072 | prostaglandin E synthase 3 (cytosolic) |
Mus musculus | 102641464 | prostaglandin E synthase 3-like |
Neospora caninum | NCLIV_004390 | p23, related |
Oryza sativa | 4333609 | Os03g0655300 |
Oryza sativa | 4332979 | Os03g0381300 |
Oryza sativa | 4345369 | Os08g0359500 |
Plasmodium berghei | PBANKA_1317400 | co-chaperone p23, putative |
Plasmodium falciparum | PF3D7_1453700 | co-chaperone p23 |
Plasmodium knowlesi | PKNH_1228400 | co-chaperone p23, putative |
Plasmodium vivax | PVX_117795 | hypothetical protein, conserved |
Plasmodium yoelii | PY00792 | 34 kDa phosphoprotein |
Saccharomyces cerevisiae | YKL117W | Sba1p |
Schistosoma japonicum | Sjp_0212790 | Protein wos2, putative |
Schistosoma mansoni | Smp_072900.1 | hsp90 co-chaperone (tebp) |
Schistosoma mansoni | Smp_072900.2 | hsp90 co-chaperone (tebp) |
Schmidtea mediterranea | mk4.001672.07 | Hsp90 co-chaperone |
Trypanosoma brucei gambiense | Tbg972.9.5930 | hypothetical protein, conserved |
Trypanosoma brucei gambiense | Tbg972.10.3260 | hypothetical protein, conserved |
Trypanosoma brucei | Tb927.9.10230 | Co-chaperone protein P23 |
Trypanosoma brucei | Tb927.10.2620 | CS domain containing protein, putative |
Trypanosoma congolense | TcIL3000_10_2240 | CS domain containing protein, putative |
Trypanosoma cruzi | TcCLB.506195.170 | CS domain containing protein, putative |
Trypanosoma cruzi | TcCLB.507007.70 | Co-chaperone protein P23 |
Trypanosoma cruzi | TcCLB.506407.60 | CS domain containing protein, putative |
Trypanosoma cruzi | TcCLB.509551.70 | Co-chaperone protein P23 |
Toxoplasma gondii | TGME49_321520 | hypothetical protein |
Theileria parva | TP02_0486 | hypothetical protein |
Trichomonas vaginalis | TVAG_007320 | butyrate induced transcript, putative |
Trichomonas vaginalis | TVAG_388410 | co-chaperone, putative |
Trichomonas vaginalis | TVAG_475160 | HSP90 co-chaperone, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.10.2620 | Trypanosoma brucei | significant gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.10.2620 | Trypanosoma brucei | significant gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.10.2620 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.10.2620 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
Tb09.211.1690 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb09.211.1690 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb09.211.1690 | Trypanosoma brucei | significant loss of fitness in procyclic forms | alsford |
Tb09.211.1690 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_ZC395.10 | Caenorhabditis elegans | embryonic lethal | wormbase |
TGME49_321520 | Toxoplasma gondii | Essentiality uncertain | sidik |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Type | Source | Notes |
---|---|---|
soluble recombinant protein | Structural Genomics for Pathogenic Protozoa (SGPP) | Lmaj005724; Recombinant protein: full-length; Source: L major; hypothetical protein, conserved ; |